BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11442493)

  • 1. Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia.
    Abu-Duhier FM; Goodeve AC; Wilson GA; Care RS; Peake IR; Reilly JT
    Br J Haematol; 2001 Jun; 113(4):983-8. PubMed ID: 11442493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia.
    Shih LY; Kuo MC; Liang DC; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Lai CL
    Cancer; 2003 Sep; 98(6):1206-16. PubMed ID: 12973844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group.
    Abu-Duhier FM; Goodeve AC; Wilson GA; Gari MA; Peake IR; Rees DC; Vandenberghe EA; Winship PR; Reilly JT
    Br J Haematol; 2000 Oct; 111(1):190-5. PubMed ID: 11091200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.
    Fröhling S; Schlenk RF; Breitruck J; Benner A; Kreitmeier S; Tobis K; Döhner H; Döhner K;
    Blood; 2002 Dec; 100(13):4372-80. PubMed ID: 12393388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia.
    Stirewalt DL; Meshinchi S; Kussick SJ; Sheets KM; Pogosova-Agadjanyan E; Willman CL; Radich JP
    Br J Haematol; 2004 Feb; 124(4):481-4. PubMed ID: 14984498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of class III receptor tyrosine kinases (C-KIT, C-FMS, FLT3) in idiopathic myelofibrosis.
    Abu-Duhier FM; Goodeve AC; Care RS; Gari M; Wilson GA; Peake IR; Reilly JT
    Br J Haematol; 2003 Feb; 120(3):464-70. PubMed ID: 12580961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias.
    Care RS; Valk PJ; Goodeve AC; Abu-Duhier FM; Geertsma-Kleinekoort WM; Wilson GA; Gari MA; Peake IR; Löwenberg B; Reilly JT
    Br J Haematol; 2003 Jun; 121(5):775-7. PubMed ID: 12780793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific detection of Flt3 point mutations by highly sensitive real-time polymerase chain reaction in acute myeloid leukemia.
    Scholl S; Krause C; Loncarevic IF; Müller R; Kunert C; Wedding U; Sayer HG; Clement JH; Höffken K
    J Lab Clin Med; 2005 Jun; 145(6):295-304. PubMed ID: 15976757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children.
    Xu F; Taki T; Yang HW; Hanada R; Hongo T; Ohnishi H; Kobayashi M; Bessho F; Yanagisawa M; Hayashi Y
    Br J Haematol; 1999 Apr; 105(1):155-62. PubMed ID: 10233379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia.
    Christiansen DH; Andersen MK; Desta F; Pedersen-Bjergaard J
    Leukemia; 2005 Dec; 19(12):2232-40. PubMed ID: 16281072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC.
    Bianchini M; Ottaviani E; Grafone T; Giannini B; Soverini S; Terragna C; Amabile M; Piccaluga PP; Malagola M; Rondoni M; Bosi C; Baccarani M; Martinelli G
    Clin Chem; 2003 Oct; 49(10):1642-50. PubMed ID: 14500589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type.
    Chen W; Jones D; Medeiros LJ; Luthra R; Lin P
    Br J Haematol; 2005 Sep; 130(5):726-8. PubMed ID: 16115128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of FLT3 ITD and D835 mutations in AML patients.
    Sheikhha MH; Awan A; Tobal K; Liu Yin JA
    Hematol J; 2003; 4(1):41-6. PubMed ID: 12692519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.
    Goemans BF; Zwaan CM; Miller M; Zimmermann M; Harlow A; Meshinchi S; Loonen AH; Hählen K; Reinhardt D; Creutzig U; Kaspers GJ; Heinrich MC
    Leukemia; 2005 Sep; 19(9):1536-42. PubMed ID: 16015387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLT3 mutations in myeloid sarcoma.
    Ansari-Lari MA; Yang CF; Tinawi-Aljundi R; Cooper L; Long P; Allan RH; Borowitz MJ; Berg KD; Murphy KM
    Br J Haematol; 2004 Sep; 126(6):785-91. PubMed ID: 15352981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FLT3 and its role in the pathogenesis of acute myeloid leukaemia.
    Reilly JT
    Leuk Lymphoma; 2003 Jan; 44(1):1-7. PubMed ID: 12691136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.
    Nakao M; Yokota S; Iwai T; Kaneko H; Horiike S; Kashima K; Sonoda Y; Fujimoto T; Misawa S
    Leukemia; 1996 Dec; 10(12):1911-8. PubMed ID: 8946930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of FLT3 oncogene mutations in acute myeloid leukemia using conformation sensitive gel electrophoresis.
    Gari M; Abuzenadah A; Chaudhary A; Al-Qahtani M; Banni H; Ahmad W; Al-Sayes F; Lary S; Damanhouri G
    Int J Mol Sci; 2008 Nov; 9(11):2194-2204. PubMed ID: 19330068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.
    Andersson A; Johansson B; Lassen C; Mitelman F; Billström R; Fioretos T
    Eur J Haematol; 2004 May; 72(5):307-13. PubMed ID: 15059064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor.
    Chillón MC; Fernández C; García-Sanz R; Balanzategui A; Ramos F; Fernández-Calvo J; González M; Miguel JF
    Hematol J; 2004; 5(3):239-46. PubMed ID: 15167911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.